Headache, the most frequent adverse event, was more frequently reported by patients receiving prucalopride.
Nausea was more frequently reported in the vortioxetine group (25% vs 4.6% for the placebo group).
Felt stigma was more frequently reported than enacted stigma, with over 70% having experienced this form of stigma.
Candida albicans infection was more frequently reported than non-albicans ones in diabetic women (Odds Ratio, OR=1.7, 95%, Confidence Interval, CI 1.1 2.7).
Subclavian CVC placement was more frequently reported as the reason for using US by residents compared to seniors [respectively, 17%% (n = 11) vs. 5%% (n = 6); p = 0.01].
Dizziness was more frequently reported by the buprenorphine group (62.1% versus 37.5%, P <0.05) but other adverse effects observed within 40 minutes were similar in the two groups.
However, Peterlin et al. (2008) in their study of migraineurs attending an outpatient headache center demonstrated that PTSD was more frequently reported among chronic migraineurs than episodic migraineurs (42.9% vs. 9.4%, p = 0.0059) [20.0059
Side shift within attacks and within bouts was more frequently reported in the CCH than in the ECH group while any type of side shift was more common in men that in women, although the differences identified did not reach statistical significance (Table 3).
Early treatment seeking was more frequently reported by those who accessed home treatment and community health workers [47].
Clinical presentation did not significantly differ between the two CBS subgroups, with the only exception of early memory impairment, that was more frequently reported in the clinical history of CBSN patients (p<0.005).
TAHBSO was more frequently reported in earlier study years.
